GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.

News Guizhou Bailing Group Pharmaceutical Co., Ltd.

Stocks

002424

CNE100000PY3

Pharmaceuticals

End-of-day quote Shenzhen S.E. 2026-09-30			5-day change	1st Jan Change
4.690 ^CNY	+1.30%		+1.74%	+7.82%

09-17	Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream	MT
09-01	Guizhou Bailing Group Pharmaceutical Gets China Clinical Trial Approval for COPD Drug	MT

All News

Mentions Relevance

09-17	Guizhou Bailing Unit Gets China Regulator's Nod to Trial Tangning Tongluo Cream	MT
09-01	Guizhou Bailing Group Pharmaceutical Gets China Clinical Trial Approval for COPD Drug	MT
08-24	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
06-22	Guizhou Bailing's Three Products Chosen for China's Centralized Procurement for Traditional Medicine	MT
05-19	Guizhou Bailing Group Pharmaceutical Gets Seven-Year Protection Status for Traditional Chinese Drug Spray	MT
04-27	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-27	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12-29	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from S&P Global BMI Index	CI
12-19	Guizhou Bailing's trading to halt to implement other risk warning	RE
12-03	Guizhou Bailing Group Pharmaceutical's actual controller investigated for suspected rule violations	RE
25-10-24	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-10-16	Guizhou Bailing's Unit Gets Nod to Trial Tangning Tongluo Tablets	MT
25-09-21	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) added to S&P Global BMI Index	CI
25-08-19	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-29	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-28	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-11-13	Bailing Pharma Gets Clinical Trial Approval for Diabetic Retinopathy Traditional Chinese Tablets; Shares Rise 5%	MT
24-10-25	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-08-27	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-08-02	Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	CI
24-08-01	Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback announced on February 3, 2024 has closed with 20,491,812 shares, representing 1.48% for CNY 119.59 million.	CI
24-07-01	Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.	CI
24-05-20	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from FTSE All-World Index	CI
24-05-09	Guizhou Bailing Group Pharmaceutical Co., Ltd.(XSEC:002424) dropped from S&P Global BMI Index	CI
24-04-29	Guizhou Bailing Group Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI